Pharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
Pharm D Solutions, LLC is recalling Sermorelin/GHRP-2 &6 vials due to a lack of sterility assurance. The recall affects products distributed nationwide in the United States.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated as Severe (4). While the specific injury reports are not detailed in the snippet, the Class II classification for a sterility issue in an injectable drug aligns with the Severe criteria due to the potential for serious harm.
Plain-English summary
Pharm D Solutions, LLC is recalling Sermorelin/GHRP-2 &6 (9-9-9-mg) vials because of a lack of sterility assurance. The affected product is identified by Lot # 05032019:29 with an expiration date of 11/02/2019. The recall is classified as Class II by the U.S. Food and Drug Administration.
The product was distributed nationwide within the United States. The source text does not specify the exact number of units recalled or the specific locations where the product was sold.
Consumers who have this product should stop using it and contact Pharm D Solutions, LLC at 1-844-263-6846 for further instructions. The company is located at 1304 South Loop West, Houston, TX 77054.
The recalled product
- Product
- Sermorelin/GHRP-2 &6 (9-9-9-mg) vials, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 05032019:29 Exp. 11/02/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Human Chorionic Gonadotropin Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 Powder Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Sermorelin Powder Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Sermorelin/Ipamorelin Powder Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereDowning Labs Recalls Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SeverePromise Pharmacy Recalls Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- CriticalNuVision Pharmacy Recalls Sermorelin/GHRP-6 Vials Due to Sterility Concerns
FDA (Drugs) · 2014-02-05